Preventing transfusion related complications in a recipient of a blood transfusion
US7648699B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Aug 31, 2006 |
| Grant date | Jan 19, 2010 |
| Priority date | — |
| Expiry date | Aug 31, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K41/0023
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention is directed toward a process for reducing transfusion related complications in a recipient of an allogeneic blood transfusion by adding to the blood to be transfused a photosensitizer comprising riboflavin, irradiating the blood and riboflavin with light, transfusing the irradiated blood into a recipient, and reducing a transfusion related complication by the recipient to cells in the donor blood. The invention is also directed towards a process for preventing rejection of a donor organ by a recipient comprising the steps of transfusing the recipient of the donor organ with treated platelets; and transplanting the donor organ into the recipient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.